Jazz Pharma to pay $145 million to settle narcolepsy drug antitrust case
Settlement resolves allegations Jazz delayed generic Xyrem launch, driving up costs for health plans and patients
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Hikma Pharmaceuticals
Riad Mishlawi named as next CEO of Hikma Pharma
Mishlawi was instrumental in the growth and global expansion of the group's injectables business into a market-leading position
Glenmark receives marketing approval for its nasal spray in 13 countries across EU and UK
Glenmark has also partnered with Hikma Pharmaceuticals PLC and Bausch Health for the commercialisation of Ryaltris in the US and…
Hikma Pharma get US FDA nod for higher dosage of naloxone nasal spray to treat opioid overdose
The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity
Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets
Hikma had said in January that it was planning to buy those assets
Glenmark Pharma and Menarini enter into exclusive licensing agreement for commercialising Ryaltris…
Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltris…
Glenmark Pharmaceuticals and Hikma enter into partnership for commercialising RyaltrisT in the US
Glenmark will be responsible for the continued development and regulatory approval of RyaltrisTM by the US FDA, while Hikma will…